D.E. Shaw & Co
SGNT

D.E. Shaw & Co’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

D.E. Shaw & Co’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-39,368
Closed -$590K – 3709
2016
Q2 		$590K Sell
39,368
-43,703
-53% -$561K ﹤0.01% 2715
2016
Q1 		$1.01M Buy
83,071
+51,917
+167% +$728K ﹤0.01% 2344
2015
Q4 		$496K Buy
+31,154
New +$490K ﹤0.01% 3100
2014
Q1 		– Sell
-11,713
Closed -$297K – 4866
2013
Q4 		$297K Sell
11,713
-83,956
-88% -$1.9M ﹤0.01% 4065
2013
Q3 		$1.95M Buy
+95,669
New +$2.13M ﹤0.01% 2450

D.E. Shaw & Co's SGNT Position: Q3 2016 in Review

D.E. Shaw & Co sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 39,368 shares — an estimated $590K sold.

D.E. Shaw & Co first reported a position in SGNT in Q3 2013 and held it in 5 quarters. The position peaked at $1.95M in Q3 2013. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

  • D.E. Shaw & Co reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • D.E. Shaw & Co sold 39,368 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $590K.
  • D.E. Shaw & Co first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q3 2013 and held it in 5 quarters.
  • D.E. Shaw & Co's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $1.95M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on D.E. Shaw & Co's 13F filing for Q3 2016, filed 14 Nov 2016.